FDA Inspection
NuCare Pharmaceuticals IncNuCare Pharmaceuticals Inc – FDA Inspection, Mar 21, 2018
Record Details
This FDA Inspection record concerns NuCare Pharmaceuticals Inc, with an inspection on March 21, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f6f938fc-85b9-408a-b78a-ee2af82edf95
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1045177
- FDA center
- Human Drugs
- Project area
- Unapproved and Misbranded Drugs
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of NuCare Pharmaceuticals Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 12, 2025 | Not classified | Los Angeles District Office | |
| January 10, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 19, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 31, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for NuCare Pharmaceuticals Inc
- FDA Inspection 1264447 - 2025-03-12
- FDA Inspection 1114915 - 2020-01-10
- FDA Inspection 1069414 - 2018-09-19
- FDA Inspection 920340 - 2015-02-13
- FDA Inspection 718535 - 2011-03-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.